{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:11:02Z","timestamp":1760807462252,"version":"build-2065373602"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:00:00Z","timestamp":1571097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Tissue Viability"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jtv.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T13:51:47Z","timestamp":1569678707000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Adverse event reporting and trial registration in venous leg ulcer trials published since the 2001 CONSORT statement revision: A systematic review"],"prefix":"10.1016","volume":"29","author":[{"given":"Andrew","family":"Jull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan","family":"Biggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jtv.2019.09.005_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2702.2003.00662.x","article-title":"Hierarchy of evidence: a framework for ranking evidence evaluating healthcare interventions","volume":"12","author":"Evans","year":"2003","journal-title":"J Clin Nurs"},{"issue":"2","key":"10.1016\/j.jtv.2019.09.005_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-199410020-00001","article-title":"Harmonisation in pharmacovigilance","volume":"10","author":"Edwards","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.jtv.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","article-title":"The revised CONSORT statement for reporting randomized trials: explanation and elaboration","volume":"134","author":"Altman","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtv.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT Statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.jtv.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinternmed.2009.306","article-title":"Reporting of safety results in published reports of randomizede controlled trials","volume":"169","author":"Pitrou","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jtv.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2013.52.2219","article-title":"Adverse event reporting in cancer clinical trial publications","volume":"32","author":"Sivendran","year":"2013","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jtv.2019.09.005_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jama.293.23.jed50037","article-title":"Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors","volume":"293","author":"DeAngelis","year":"2005","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.jtv.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1001\/jamainternmed.2018.8009","article-title":"Evaluation of journal registration policies and prospective registration of randomized clinical trials of nonregulated health care interventions","volume":"179","author":"Azar","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtv.2019.09.005_bib9","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2014.04.049","article-title":"Management of venous leg ulcers: clinical practice guidelines for the Society for Vascular Surgery and the American Venous Forum","volume":"60","author":"O'Donnell","year":"2014","journal-title":"J Vasc Surg"},{"year":"2006","series-title":"Guidance for industry chronic cutaneous ulcer and burn wounds \u2014 developing products for treatment","author":"Food and Drug Administration","key":"10.1016\/j.jtv.2019.09.005_bib10"},{"issue":"5","key":"10.1016\/j.jtv.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1600-0536.2003.00111.x","article-title":"Allergic contact dermatitis in venous leg ulcer patients","volume":"48","author":"Tavadia","year":"2003","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.jtv.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.12968\/jowc.2015.24.5.211","article-title":"Heterogeneity of wound outcome measures in RCTs of treatments for VLUs: a systematic review","volume":"24","author":"Gethin","year":"2015","journal-title":"J Wound Care"},{"key":"10.1016\/j.jtv.2019.09.005_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/wrr.12756","article-title":"External validity of randomized controlled trials of interventions in venous leg ulceration: a systematic review","author":"Gethin","year":"2019","journal-title":"Wound Repair Regen"},{"year":"2011","series-title":"Cochrane handbook for systematic reviews of interventions 5.1.0 [updated march 2011]. The Cochrane collaboration, 2011","key":"10.1016\/j.jtv.2019.09.005_bib14"},{"issue":"4","key":"10.1016\/j.jtv.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.sla.0000258943.94661.b7","article-title":"Consensus statement of mandatory registration of clinical trials","volume":"245","year":"2007","journal-title":"Ann Surg"},{"issue":"57","key":"10.1016\/j.jtv.2019.09.005_bib16","doi-asserted-by":"crossref","DOI":"10.3310\/hta18570","article-title":"VenUS IV (Venous leg Ulcer Study IV) \u2013 compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model","volume":"18","author":"Ashby","year":"2014","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtv.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1067-1927.2004.012205.x","article-title":"Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers","volume":"12","author":"Liu","year":"2014","journal-title":"Wound Repair Regen"},{"year":"2007","series-title":"Manuka Honey vs. Hydrogel \u2013 a prospective, open label, multicentre, randomised controlled trial to compare desloughing efficacy and healing outcomes in venous ulcers","author":"Gethin","key":"10.1016\/j.jtv.2019.09.005_bib18"},{"key":"10.1016\/j.jtv.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ijnurstu.2014.11.008","article-title":"Endorsement of the CONSORT guidelines, trial registration, and the quality of reporting randomised controlled trials in leading nursing journals: a cross-sectional analysis","volume":"52","author":"Jull","year":"2015","journal-title":"Int J Nurs Stud"},{"issue":"2","key":"10.1016\/j.jtv.2019.09.005_bib20","first-page":"27","article-title":"Meeting report: core outcome set for venous leg ulceration \u201cCoreVen\u201d","volume":"18","author":"Hallas","year":"2017","journal-title":"EWMA Journal"},{"key":"10.1016\/j.jtv.2019.09.005_bib21","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jtv.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0266462312000086","article-title":"The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies","volume":"28","author":"Morrison","year":"2012","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Journal of Tissue Viability"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965206X19300385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965206X19300385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:52:15Z","timestamp":1760806335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965206X19300385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0965206X19300385"],"URL":"https:\/\/doi.org\/10.1016\/j.jtv.2019.09.005","relation":{},"ISSN":["0965-206X"],"issn-type":[{"type":"print","value":"0965-206X"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse event reporting and trial registration in venous leg ulcer trials published since the 2001 CONSORT statement revision: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Tissue Viability","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtv.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Tissue Viability Society.","name":"copyright","label":"Copyright"}]}}